Korean Circ J.  2019 Aug;49(8):678-690. 10.4070/kcj.2019.0163.

Pediatric Ventricular Assist Device

Affiliations
  • 1Division of Cardiovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. hank@yuhs.ac

Abstract

There have been great advances in ventricular assist device (VAD) treatment for pediatric patients with advanced heart failure. VAD support provides more time for the patient in the heart transplant waiting list. Augmented cardiac output improves heart failure symptoms, end-organ function, and general condition, and consequently provides beneficial effects on post-transplant outcomes. Miniaturized continuous flow devices are more widely adopted for pediatric patient with promising results. For infants and small children, still paracorporeal pulsatile device is the only option for long-term support. Younger age, congenital heart disease, biventricular support, patient's status and end-organ dysfunction at the time of implantation are risks for poor outcomes. Patient selection, timing of implantation, and selection of device for each patient are critical for optimal clinical outcomes.

Keyword

Heart failure; Pediatric; Ventricular assist device; Extracorporeal membranous oxygenation; Cardiac transplantation

MeSH Terms

Cardiac Output
Child
Heart
Heart Defects, Congenital
Heart Failure
Heart Transplantation
Heart-Assist Devices*
Humans
Infant
Patient Selection
Waiting Lists
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error